Skip to main content
Clinical Trials/CTRI/2019/01/016899
CTRI/2019/01/016899Not yet recruiting未知

Addressing Smokeless Tobacco and building Research Capacity in South Asia - ASTRA

ational Institute of Health Research UK0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Self-reported daily users of ST products at least for the last 6 months or ST use on >25 days in the past month
  • 2.Able to provide informed consent
  • 3.Motivated and willing to quit ST use within the next 30 days

Exclusion Criteria

  • 1.Self-reported users of any combustible tobacco product (cigarettes, bidis, hookah) or e-cigarettes in the past 30 days or those having Carbon monoxide (CO) levels >10ppm, identified by a breath test.
  • 2.Pregnant or breastfeeding women.
  • 3.Individuals with health conditions, which warrant caution in using NRT and have previously been excluded in trials of nicotine replacement in smoking. These will be assessed by participant self-report at the pre-trial screening by asking participants whether they have suffered angina pectoris, myocardial infarction or stroke the past three weeks.
  • 4.Individuals who are already on an existing treatment, either pharmacological or behavioral, for tobacco cessation.
  • 5.ST using individuals with diagnosis or oral cancer. Due to the nature of care required, any such individuals identified during the recruitment process will receive a direct referral to specialist care for treatment.

Investigators

Sponsor
ational Institute of Health Research UK

Similar Trials